bluebird bio, Inc.
TIM3 HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE

Last updated:

Abstract:

The invention provides improved genome editing compositions and methods for editing a TIM3 gene. The invention further provides genome edited cells for the prevention, treatment, or amelioration of at least one symptom of, a cancer, an infectious disease, an autoimmune disease, an inflammatory disease, or an immunodeficiency.

Status:
Application
Type:

Utility

Filling date:

23 Aug 2017

Issue date:

29 Aug 2019